Betaloc, solution for injections 1mg/ml, 5ml x 5 ampoules — Made in Sweden — Free Delivery

Supraventricular tachyarrhythmia.

Prevention and treatment of myocardial ischemia, tachyarrhythmia and pain if myocardial infarction is suspected or diagnosed.

Cardiogenic shock.

Sinus node weakness syndrome (in the absence of a permanent pacemaker).

Blockade of the second and third degree.

Unstable, uncompensated heart failure (pulmonary edema, hypoperfusion or arterial hypotension) continuous or intermittent inotropic therapy with beta-adrenergic agonists.

Symptomatic bradycardia or arterial hypotension. Metoprolol should not be given to patients with suspected acute myocardial infarction as long as the heart rate is <45 beats/min, the P-Q interval is >0.24 seconds, or the systolic blood pressure is <100 mmHg.

Systolic blood pressure below 110 mmHg. in patients with supraventricular tachyarrhythmias.

Serious peripheral vascular disease with the threat of gangrene.

Hypersensitivity to metoprolol tartrate or other beta-blockers or any of the excipients has been established.

active ingredient: metoprolol tartrate;

1 ml solution for injection contains metoprolol tartrate 1 mg

excipients: sodium chloride, water for injection.

Parenteral administration of Betaloc should be carried out under the supervision of specially trained personnel in institutions where blood pressure can be measured, ECG done and resuscitation carried out.

At the initial stage, the drug at a dose of 5 mg (= 5 ml) must be administered at a rate of 1-2 mg / min. The introduction of the drug in this dose can be repeated every 5 minutes until the desired effect is achieved. Usually a total dose of 10-15 mg (= 10-15 ml) is sufficient. The recommended maximum dose for intravenous administration is 20 mg (= 20 ml).

Acute condition the drug should be administered at a dose of 5 mg (= 5 ml). This dose may be repeated every 2 minutes; the maximum dose is 15 mg (= 15 ml). 15 minutes after the last injection, 50 mg of metoprolol tartrate should be administered orally every 6:00 for 48 hours. For long-term (reception) use, Betaloc ZOK sustained-release tablets should be prescribed.

For information on when such treatment should not be prescribed, see the sections "Contraindications" and "Peculiarities of use".

The diluted solution for injection should be used within 12:00.

Renal function only slightly affects the rate of elimination of the drug, so there is no need to adjust the dose of the drug for patients with impaired renal function.

Usually, patients suffering from cirrhosis of the liver can be prescribed the same dose of metoprolol as patients with normal liver function. Only in the case of evidence of very severe hepatic impairment (eg, patients undergoing bypass surgery) should dose reduction be considered.

Dose adjustment of the drug is not required.

Experience in treating children with Betaloc is limited.